AstraZeneca's Truqap approved in the US for HR-positive breast cancer
AstraZeneca's Truqap approved in the US for HR-positive breast cancer
Stay updated with breaking news from Correlative Analysis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
AstraZeneca's Truqap approved in the US for HR-positive breast cancer
Tessa Therapeutics Announces Updated Safety, Efficacy and Biomarker Data from Phase 2 Trial of Autologous CD30.CAR-T Therapy (TT11) in Relapsed or Refractory Classical Hodgkin Lymphoma GlobeNewswire December 12, 2022 Updated Results from CHARIOT Phase 2 trial presented at the 2022 ASH Annual Meeting indicate a 73.3% overall response rate and 60% complete...
New data from clinical trials of TT11 and TT11X to be featured in two oral podium presentations and a poster presentationSINGAPORE, Nov. 03, 2022 (Tessa), a clinical-stage cell therapy company developing
Digital Surf today announced the release of Mountains® 9, a major new version of the company's leading software platform for image and surface analysis in microscopy and metrology.